Why Stryker Corporation (SYK) stock moved
Stryker Corporation (SYK) shares fell 0.2% to $319.14 as of July 21, 2026, a slight decline from the prior close of $319.87. BestStocks flagged the session as a major change for SYK. Below, we break down what changed for SYK, why it matters for investors, how the stock reacted, and the catalysts on the calendar.
SYK fell 0.2% to $319.14
SYK fell 0.2% in its latest session, moving from $319.87 to $319.14.
What it means for Stryker Corporation investors
For Stryker Corporation investors, the recent signals add up to a bearish shift. On the constructive side: Stryker announced the U.S. commercial launch of Mako RPS, a handheld robotic technology that expands its Mako platform into knee replacement procedures for a new market segment (PR Newswire); Positive price momentum. Weighing against that: Negative session, down 0.2%; Stryker Corporation (SYK) moved -3.42% from $331.20 to $319.87 on 2026-07-17. Wall Street's consensus price target sits at $381.79, implying +19.6% upside from $319.14. Over the past 90 days analysts logged 1 upgrade and 0 downgrades. BestStocks rates the overall signal quality weak (0/100). With earnings roughly 9 days out, the next report is the most likely near-term test of the move.
SYK price reaction
SYK last traded at $319.14, down $0.73 (-0.23%) from the previous close of $319.87. The session traded on 0.4× average volume (below avg), so participation was unremarkable. Over the past month the stock has ranged between $304.69 and $332.71, and it currently sits about 52% of the way up that band.
Bullish and bearish analyst opinions on Stryker Corporation (SYK)
The consensus analyst price target on Stryker Corporation (SYK) is $381.79, 19.6% above the recent $319.14. Over the past 90 days analysts logged 1 upgrade, 10 maintains, and 0 downgrades. Here is how the bullish and bearish cases on SYK line up.
The bullish case
- Wall Street's consensus price target of $381.79 implies +19.6% upside from $319.14.
- The Street's most bullish target is $465.00 (+45.7%).
- 1 analyst upgrade in the past 90 days, most recently BMO Capital to Outperform (2026-07-09).
- Stryker announced the U.S. commercial launch of Mako RPS, a handheld robotic technology that expands its Mako platform into knee replacement procedures for a new market segment (PR Newswire).
- Positive price momentum.
The bearish case
- The most bearish analyst target is $315.00 (-1.3%).
- Negative session, down 0.2%.
- Stryker Corporation (SYK) moved -3.42% from $331.20 to $319.87 on 2026-07-17.
- SYK declined 3.73% intraday to $318.18.
Weighing both sides, BestStocks' composite read of recent signals is bearish, as the bull-versus-bear meter above shows. This is an educational summary of the bull and bear case, not investment advice.
Analyst price targets and ratings are FMP consensus figures as of Jul 21, 2026; other aggregators may differ. High and low targets show the range of estimates, not forecasts.
Previous notable changes for SYK
Frequently asked questions about SYK
Why did Stryker Corporation (SYK) stock move?
SYK fell 0.2% to $319.14. No single company-specific catalyst was confirmed during the move window, and it looks technical.
How much did SYK stock fall?
SYK lost 0.23% ($0.73) versus the prior close of $319.87, last trading at $319.14 on 0.4× average volume.
When is Stryker Corporation's next earnings date?
SYK's next earnings report is estimated for 2026-07-30 — about 9 days away.
What is the analyst price target for SYK?
The consensus analyst price target for SYK is $381.79, about 19.6% above the current $319.14. Over the past 90 days, analysts recorded 1 upgrade, 10 maintains, and 0 downgrades.
How BestStocks tracks SYK
This page is generated automatically by BestStocks' change-detection system after its price and volume cleared SYK-specific materiality thresholds, triggering an evidence check. It draws on 8 tracked change events for SYK, cross-checked against the data sources listed below. Price, volume, and market-capitalization figures are the live intraday quote as of July 21, 2026 and refresh as new information is detected; for companies with multiple share classes, market-cap figures can differ by data source. Analyst price targets and ratings are FMP consensus. This is an educational summary of what changed and why — not personalized investment advice.